Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.

PLoS neglected tropical diseases - 1 Jan 2013

Coeli Regina, Baba Elio H, Araujo Neusa, Coelho Paulo M Z, Oliveira Guilherme

Abstract excerpt

BACKGROUND: Schistosomiasis has a considerable impact on public health in many tropical and subtropical areas. In the new world, schistosomiasis is caused by the digenetic trematode Schistosoma mansoni. Chemotherapy is the main measure for controlling schistosomiasis, and the current drug of choice for treatment is praziquantel (PZQ). Although PZQ is efficient and safe, its repetitive large-scale use in endemic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anthelmintics
Share to Drug Resistance
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microsatellite Repeats

Share to Schistosoma mansoni

Share to Schistosomiasis mansoni

Share to Selection, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 24367712
DOI: 10.1371/journal.pntd.0002596
PMCID: PMC3868512

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.PMID 24367712Read ↗

Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.Semantic proximity Read ↗

Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.Semantic proximity Read ↗

Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal.Semantic proximity Read ↗

Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania.Semantic proximity Read ↗

The influence of drug treatment on the maintenance of schistosome genetic diversity.Semantic proximity Read ↗

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.Semantic proximity Read ↗

Population genetics of Schistosoma haematobium: development of novel microsatellite markers and their application to schistosomiasis control in Mali.Semantic proximity Read ↗

No apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in mwea, central kenya, a heavy transmission area.Semantic proximity Read ↗

Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition.Semantic proximity Read ↗

Inhibition or Knockdown of ABC Transporters Enhances Susceptibility of Adult and Juvenile Schistosomes to PraziquantelSemantic proximity Read ↗

Brazilian studies on the genetics of Schistosoma mansoni.Semantic proximity Read ↗

Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.